Literature DB >> 4130354

The clinical use of actinomycin.

E Frei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4130354

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  10 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer.

Authors:  Jeffrey M Skolnik; Alena Y Zhang; Jeffrey S Barrett; Peter C Adamson
Journal:  Ther Drug Monit       Date:  2010-12       Impact factor: 3.681

4.  The actinomycin biosynthetic gene cluster of Streptomyces chrysomallus: a genetic hall of mirrors for synthesis of a molecule with mirror symmetry.

Authors:  Ullrich Keller; Manuel Lang; Ivana Crnovcic; Frank Pfennig; Florian Schauwecker
Journal:  J Bacteriol       Date:  2010-03-19       Impact factor: 3.490

5.  Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.

Authors:  M J Soble; R T Dorr; P Plezia; S Breckenridge
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Epidermal growth factor and insulin-like growth factor-1 protect MDA-231 cells from death induced by actinomycin D: the involvement of growth factors in drug resistance.

Authors:  A Geier; R Hemi; M Haimsohn; R Beery; Z Malik; A Karasik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-05       Impact factor: 2.416

7.  Diastereomeric bactericidal effect of Ru(phenanthroline)2 dipyridophenazine.

Authors:  Anna K F Mårtensson; Mattias Bergentall; Valentina Tremaroli; Per Lincoln
Journal:  Chirality       Date:  2016-11       Impact factor: 2.437

8.  Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.

Authors:  Roman Mezencev; Lijuan Wang; John F McDonald
Journal:  J Ovarian Res       Date:  2012-10-18       Impact factor: 4.234

Review 9.  ABC transporters in CSCs membranes as a novel target for treating tumor relapse.

Authors:  Laura Zinzi; Marialessandra Contino; Mariangela Cantore; Elena Capparelli; Marcello Leopoldo; Nicola A Colabufo
Journal:  Front Pharmacol       Date:  2014-07-10       Impact factor: 5.810

Review 10.  Therapeutic value of steroidal alkaloids in cancer: Current trends and future perspectives.

Authors:  Prasanta Dey; Amit Kundu; Hirak Jyoti Chakraborty; Babli Kar; Wahn Soo Choi; Byung Mu Lee; Tejendra Bhakta; Atanas G Atanasov; Hyung Sik Kim
Journal:  Int J Cancer       Date:  2019-01-21       Impact factor: 7.396
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.